SCHEMBL1507658

SCHEMBL1507658

C#Cc1cccc(Nc2ncnc3cc(Cl)c(Oc4ccc(Cl)cc4)cc23)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.64
FBP1 P09467 3/20 0.64
GAK O14976 3/20 0.64
MAPT P10636 3/20 0.64
ALDH1A1 P00352 2/20 0.64
ERBB2 P04626 3/20 0.59
RIPK2 O43353 2/20 0.59
BUB1 O43683 2/20 0.59
STK10 O94804 2/20 0.59
MAP3K1 Q13233 2/20 0.59
PIP4K2C Q8TBX8 2/20 0.59
SLK Q9H2G2 2/20 0.59
ABL1 P00519 2/20 0.59
LMNA P02545 2/20 0.59
RAF1 P04049 2/20 0.59
CYP3A4 P08684 2/20 0.59
SRC P12931 2/20 0.59
ABL2 P42684 2/20 0.59
MKNK1 Q9BUB5 2/20 0.59
ABCG2 Q9UNQ0 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1507656 0.95 EGFR (0.59) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507674 0.93 EGFR (0.66) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507525 0.92 EGFR (0.71) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507735 0.92 EGFR (0.65) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507707 0.92 EGFR (0.62) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507726 0.91 EGFR (0.64) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507458 0.91 EGFR (0.63) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507655 0.88 EGFR (0.62) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507671 0.88 EGFR (0.60) EGFRFBP1GAKMAPTALDH1A1
SCHEMBL1507555 0.87 EGFR (0.61) EGFRFBP1GAKMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3103799-A1 QUINAZOLINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2016-12-14 EP disclosed
EP-2295415-A1 Quinazoline derivatives OSI Pharmaceuticals, Inc. (US) 2011-03-16 EP disclosed
EP-2163546-A1 Quinazoline derivatives Pfizer Products Incorporated (US) 2010-03-17 EP disclosed
EP-0817775-B1 QUINAZOLINE DERIVATIVES PFIZER (US) 2001-09-12 EP disclosed
EP-1110953-A1 Quinazoline derivatives PFIZER INC. (US) 2001-06-27 EP disclosed